Preformed Line Products (PLPC) officer exercises options, exits shares

Rhea-AI Filing Summary

Preformed Line Products reported an insider equity transaction by an officer who serves as VP, US Manufacturing. On 12/12/2025, the officer exercised employee stock options to acquire 1,000 common shares at $132.4 per share and disposed of 1,000 common shares at $207.23 per share, resulting in no directly held common shares after the transactions.

After these transactions, the officer held 6,500 employee stock options with a $132.4 exercise price and 681 restricted stock units. The options relate to a 7,500-option grant on December 11, 2024, of which 3,750 vested on December 11, 2025, with additional tranches of 1,875 vesting on December 11, 2026, and 1,875 on December 11, 2027. The options expire 10 years from the grant date, and the restricted stock units vest three years from their grant dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morcos Assaad A

(Last) (First) (Middle)

660 BETA DRIVE

(Street)

CLEVELAND OH 44143

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PREFORMED LINE PRODUCTS CO [ PLPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, US Manufacturing

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, $2 par value per share	12/12/2025		M		1,000(1)	A	$132.4	1,000	D
Common Shares, $2 par value per share	12/12/2025		D		1,000	D	$207.23	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock option (right to buy)	$132.4	12/12/2025		M			1,000(1)	(1)	(1)	Common Shares, $2 par value per share	1,000	$132.4	6,500	D
Restricted stock units	$0							(2)	(2)	Common shares, $2 par value	681		681	D

Explanation of Responses:

1. On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.

2. Restricted stock units vest 3 years from the date of grant.

Remarks:

	/s/ Caroline S Vaccariello, by power of attorney	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PLPC disclose for its VP, US Manufacturing?

The disclosure shows that a Preformed Line Products officer serving as VP, US Manufacturing exercised employee stock options for 1,000 common shares at $132.4 and disposed of 1,000 common shares at $207.23 on 12/12/2025.

How many PLPC shares did the officer own after the reported transaction?

Following the reported transactions, the officer directly owned 0 common shares, while still holding 6,500 employee stock options and 681 restricted stock units.

What stock options does the PLPC officer hold after the 12/12/2025 transactions?

The officer holds 6,500 employee stock options with a $132.4 exercise price, relating to a 7,500-option grant made on December 11, 2024.

What is the vesting schedule of the 7,500 PLPC stock options granted on December 11, 2024?

Of the 7,500 options granted on December 11, 2024, 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.

How do the PLPC restricted stock units for this officer vest?

The disclosure states that the officer holds 681 restricted stock units tied to PLPC common shares and that these restricted stock units vest 3 years from their respective grant dates.

What types of PLPC securities are reported in this insider transaction?

The report covers common shares of Preformed Line Products, employee stock options (rights to buy common shares at $132.4), and restricted stock units representing 681 common shares.